Stillman Chronic Disease Research and Training Shared Facility

斯蒂尔曼慢性病研究和培训共享设施

基本信息

  • 批准号:
    10795454
  • 负责人:
  • 金额:
    $ 799.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-08 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary / Abstract The Stillman Chronic Disease Research and Training Shared Facility will be new construction and serve as the College’s first facility dedicated entirely to research. The research focus in chronic diseases leading to health disparities is aligned with our faculty members’ interests, our established collaborations, and the health disparities in the state, the region, and the community. This facility will enhance institution-wide research programs and facilitate collaborations with research intensive partners to transform the department to one that develops relevant research programs, building upon existing biomedical pipeline initiatives. Stillman College is a historically black liberal arts college (HBCU) that was founded in 1876 in Tuscaloosa, Alabama. Located on a 105-acre former slave plantation, Stillman is known for producing African American biomedical scientists who excel in the health professions and research. According to the National Science Foundation (NSF), National Center for Science and Engineering Statistics, Survey of Earned Doctorates, Stillman graduates earned 35 PhDs between 2010 and 2020 and ranked 17th of baccalaureate HBCUs producing PhDs. This is significant because the student population represents more than 80% Pell recipients and 1st generation in college, averages 700 full-time students and 100 graduates each year. Out of the 100 biology majors, Stillman produces 25 graduates annually and more than 50% enroll in biomedical graduate programs. The Department’s goals in the Stillman Strategic Plan (2017-2022) are to: 1. Increase retention, 2. Increase the number of students entering Summer Research Programs, 3. To have a 90 percent first time pass rate on the Senior Exit Exam and Senior Thesis Research Paper and Presentation, and 4. To increase the number of graduates entering graduate and/or professional schools. Stillman College qualifies as an Institution of Emerging Excellence (IEE) based on all the criteria in 42 USC 283k(c)(2): Stillman has a research program focused on cardiovascular diseases and other health disparities. According to the CDC, the leading causes of death in Alabama are Stroke (ranks 2nd in the nation), heart disease (4th), and Alzheimer’s disease (5th). Alabama is in the Stroke Belt; 14 counties have stroke mortality rates greater than 50% of the nation’s rate and mortality is 35% higher in African Americans (61.7) than Caucasians (45.7). Alabama is also designated as an EPSCoR state. Stillman is in the poorest census tract in the city, has the highest concentration of African Americans (97%), and is designated an Opportunity Zone. The Stillman Chronic Disease Research and Training Shared Facility will enable Stillman faculty, students, and collaborators to develop research expertise in cardiovascular and other chronic diseases that produce health disparities in African Americans.
项目概要/摘要 斯蒂尔曼慢性病研究和培训共享设施将新建并服务 作为学院第一个完全致力于研究的机构,研究重点是导致慢性疾病的疾病。 健康差异与我们教职员工的利益、我们既定的合作以及健康状况相一致 该设施将加强整个机构的研究。 计划并促进与研究密集型合作伙伴的合作,将该部门转变为一个 以现有生物医学管道计划为基础,制定相关研究计划。 斯蒂尔曼学院是一所历史悠久的黑人文理学院 (HBCU),于 1876 年在塔斯卡卢萨成立, 斯蒂尔曼位于阿拉巴马州一座占地 105 英亩的前奴隶种植园内,以生产非裔美国人而闻名。 据《国家科学》报道,​​在健康专业和研究领域表现出色的生物医学科学家。 基金会 (NSF)、国家科学与工程统计中心、获得博士学位的调查、 斯蒂尔曼毕业生在 2010 年至 2020 年间获得了 35 个博士学位,在 HBCU 学士学位中排名第 17 位 这一点意义重大,因为学生人数占佩尔奖获得者的 80% 以上。 大学第一代,每年平均有 700 名全日制学生和 100 名毕业生。 生物专业,斯蒂尔曼培养了25名毕业生,超过50%就读生物医学研究生 该部门在斯蒂尔曼战略计划(2017-2022)中的目标是:1. 提高保留率,2. 增加参加暑期研究项目的学生数量,3. 首次通过率达到 90% 高级结业考试和高级论文研究论文和演示的比率,以及 4. 提高 进入研究生院和/或专业学校的毕业生人数。 斯蒂尔曼学院根据 42 USC 的所有标准获得新兴卓越学院 (IEE) 资格 283k(c)(2):斯蒂尔曼有一个专注于心血管疾病和其他健康差异的研究项目。 根据疾病预防控制中心的数据,阿拉巴马州的主要死亡原因是中风(全国排名第二)、心脏病 疾病(第 4 位)和阿尔茨海默病(第 5 位)位于中风带;14 个县有中风死亡率。 非洲裔美国人的死亡率 (61.7) 高于全国 50%,死亡率高出 35% 白人 (45.7) 也被指定为 EPSCoR 州,斯蒂尔曼位于全美最贫困的人口普查区。 该市是非裔美国人最集中的城市(97%),被指定为机会区。 斯蒂尔曼慢性病研究和培训共享设施将使斯蒂尔曼教职员工、学生和 合作者开发心血管和其他慢性疾病方面的研究专业知识,从而促进健康 非裔美国人的不平等。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROSIANNA R GRAY其他文献

ROSIANNA R GRAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
  • 批准号:
    10735151
  • 财政年份:
    2023
  • 资助金额:
    $ 799.94万
  • 项目类别:
Integrating Genomic Risk Assessment for Chronic Disease Management in a Diverse Population
整合基因组风险评估以进行不同人群的慢性病管理
  • 批准号:
    10852376
  • 财政年份:
    2023
  • 资助金额:
    $ 799.94万
  • 项目类别:
Career Enhancement Core-001
职业提升核心-001
  • 批准号:
    10660385
  • 财政年份:
    2023
  • 资助金额:
    $ 799.94万
  • 项目类别:
Identification of Trichomonas vaginalis resistance targets to inform future drug development
确定阴道毛滴虫耐药靶标,为未来药物开发提供信息
  • 批准号:
    10462312
  • 财政年份:
    2023
  • 资助金额:
    $ 799.94万
  • 项目类别:
Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer
用于预测侵袭性前列腺癌的种族相关 MRI 分析和建模
  • 批准号:
    10659602
  • 财政年份:
    2023
  • 资助金额:
    $ 799.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了